Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Geraldine DAWSON |
Documents disponibles écrits par cet auteur (86)
Faire une suggestion Affiner la recherche
Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder / Abigail BANGERTER in Journal of Autism and Developmental Disorders, 50-6 (June 2020)
Complexity analysis of head movements in autistic toddlers / Pradeep Raj KRISHNAPPA BABU in Journal of Child Psychology and Psychiatry, 64-1 (January 2023)
[article]
Titre : Complexity analysis of head movements in autistic toddlers Type de document : Texte imprimé et/ou numérique Auteurs : Pradeep Raj KRISHNAPPA BABU, Auteur ; J. Matias DI MARTINO, Auteur ; Zhuoqing CHANG, Auteur ; Sam PEROCHON, Auteur ; Rachel AIELLO, Auteur ; Kimberly L.H. CARPENTER, Auteur ; Scott COMPTON, Auteur ; Naomi DAVIS, Auteur ; Lauren FRANZ, Auteur ; Steven ESPINOSA, Auteur ; Jacqueline FLOWERS, Auteur ; Geraldine DAWSON, Auteur ; Guillermo SAPIRO, Auteur Article en page(s) : p.156-166 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Background Early differences in sensorimotor functioning have been documented in young autistic children and infants who are later diagnosed with autism. Previous research has demonstrated that autistic toddlers exhibit more frequent head movement when viewing dynamic audiovisual stimuli, compared to neurotypical toddlers. To further explore this behavioral characteristic, in this study, computer vision (CV) analysis was used to measure several aspects of head movement dynamics of autistic and neurotypical toddlers while they watched a set of brief movies with social and nonsocial content presented on a tablet. Methods Data were collected from 457 toddlers, 17-36 months old, during their well-child visit to four pediatric primary care clinics. Forty-one toddlers were subsequently diagnosed with autism. An application (app) displayed several brief movies on a tablet, and the toddlers watched these movies while sitting on their caregiver's lap. The front-facing camera in the tablet recorded the toddlers' behavioral responses. CV was used to measure the participants' head movement rate, movement acceleration, and complexity using multiscale entropy. Results Autistic toddlers exhibited significantly higher rate, acceleration, and complexity in their head movements while watching the movies compared to neurotypical toddlers, regardless of the type of movie content (social vs. nonsocial). The combined features of head movement acceleration and complexity reliably distinguished the autistic and neurotypical toddlers. Conclusions Autistic toddlers exhibit differences in their head movement dynamics when viewing audiovisual stimuli. Higher complexity of their head movements suggests that their movements were less predictable and less stable compared to neurotypical toddlers. CV offers a scalable means of detecting subtle differences in head movement dynamics, which may be helpful in identifying early behaviors associated with autism and providing insight into the nature of sensorimotor differences associated with autism. En ligne : https://doi.org/10.1111/jcpp.13681 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=490
in Journal of Child Psychology and Psychiatry > 64-1 (January 2023) . - p.156-166[article] Complexity analysis of head movements in autistic toddlers [Texte imprimé et/ou numérique] / Pradeep Raj KRISHNAPPA BABU, Auteur ; J. Matias DI MARTINO, Auteur ; Zhuoqing CHANG, Auteur ; Sam PEROCHON, Auteur ; Rachel AIELLO, Auteur ; Kimberly L.H. CARPENTER, Auteur ; Scott COMPTON, Auteur ; Naomi DAVIS, Auteur ; Lauren FRANZ, Auteur ; Steven ESPINOSA, Auteur ; Jacqueline FLOWERS, Auteur ; Geraldine DAWSON, Auteur ; Guillermo SAPIRO, Auteur . - p.156-166.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 64-1 (January 2023) . - p.156-166
Index. décimale : PER Périodiques Résumé : Background Early differences in sensorimotor functioning have been documented in young autistic children and infants who are later diagnosed with autism. Previous research has demonstrated that autistic toddlers exhibit more frequent head movement when viewing dynamic audiovisual stimuli, compared to neurotypical toddlers. To further explore this behavioral characteristic, in this study, computer vision (CV) analysis was used to measure several aspects of head movement dynamics of autistic and neurotypical toddlers while they watched a set of brief movies with social and nonsocial content presented on a tablet. Methods Data were collected from 457 toddlers, 17-36 months old, during their well-child visit to four pediatric primary care clinics. Forty-one toddlers were subsequently diagnosed with autism. An application (app) displayed several brief movies on a tablet, and the toddlers watched these movies while sitting on their caregiver's lap. The front-facing camera in the tablet recorded the toddlers' behavioral responses. CV was used to measure the participants' head movement rate, movement acceleration, and complexity using multiscale entropy. Results Autistic toddlers exhibited significantly higher rate, acceleration, and complexity in their head movements while watching the movies compared to neurotypical toddlers, regardless of the type of movie content (social vs. nonsocial). The combined features of head movement acceleration and complexity reliably distinguished the autistic and neurotypical toddlers. Conclusions Autistic toddlers exhibit differences in their head movement dynamics when viewing audiovisual stimuli. Higher complexity of their head movements suggests that their movements were less predictable and less stable compared to neurotypical toddlers. CV offers a scalable means of detecting subtle differences in head movement dynamics, which may be helpful in identifying early behaviors associated with autism and providing insight into the nature of sensorimotor differences associated with autism. En ligne : https://doi.org/10.1111/jcpp.13681 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=490 Concomitant medication use in children with autism spectrum disorder: Data from the Autism Biomarkers Consortium for Clinical Trials / Logan SHURTZ in Autism, 27-4 (May 2023)
[article]
Titre : Concomitant medication use in children with autism spectrum disorder: Data from the Autism Biomarkers Consortium for Clinical Trials Type de document : Texte imprimé et/ou numérique Auteurs : Logan SHURTZ, Auteur ; Chloe SCHWARTZ, Auteur ; Charlotte DISTEFANO, Auteur ; James C MCPARTLAND, Auteur ; April R LEVIN, Auteur ; Geraldine DAWSON, Auteur ; Natalia M KLEINHANS, Auteur ; Susan FAJA, Auteur ; Sara J WEBB, Auteur ; Frederick SHIC, Auteur ; Adam J NAPLES, Auteur ; Helen SEOW, Auteur ; Raphael A BERNIER, Auteur ; Katarzyna CHAWARSKA, Auteur ; Catherine A SUGAR, Auteur ; James DZIURA, Auteur ; Damla SENTURK, Auteur ; Megha SANTHOSH, Auteur ; Shafali S JESTE, Auteur Article en page(s) : p.952-966 Langues : Anglais (eng) Mots-clés : aberrant behavior checklist,antipsychotics,autism spectrum disorders,clinical trials,medications,Vineland Adaptive Behavior Scales Index. décimale : PER Périodiques Résumé : Children with autism spectrum disorder are prescribed various medications to address behavior and mood. In clinical trials, individuals taking concomitant psychotropic medications often are excluded to maintain homogeneity and prevent contamination of clinical endpoints. However, this choice may compromise the representativeness of the sample. In a recent study designed to identify biomarkers and endpoints for clinical trials (the Autism Biomarkers Consortium for Clinical Trials), school-age children with autism spectrum disorder were enrolled without excluding for medications, providing the opportunity to examine characteristics of psychotropic medication use and guide future decisions on medication-related inclusion criteria. The aims of the current analysis were (1) to quantify the frequency and type of psychotropic medications reported in school-age children enrolled in the study and (2) to examine behavioral features of children with autism spectrum disorder based on medication classes. Of the 280 children with autism spectrum disorder in the cohort, 42.5% were taking psychotropic medications, with polypharmacy in half. The most commonly reported psychotropic medications included melatonin, stimulants, selective serotonin reuptake inhibitors, alpha agonists, and antipsychotics. Our findings suggest that exclusion of children taking concomitant psychotropic medications could limit the representativeness of the study population, perhaps even excluding children who may most benefit from new treatment options.Lay abstractChildren with autism spectrum disorder are prescribed a variety of medications that affect the central nervous system (psychotropic medications) to address behavior and mood. In clinical trials, individuals taking concomitant psychotropic medications often are excluded to maintain homogeneity of the sample and prevent contamination of biomarkers or clinical endpoints. However, this choice may significantly diminish the clinical representativeness of the sample. In a recent multisite study designed to identify biomarkers and behavioral endpoints for clinical trials (the Autism Biomarkers Consortium for Clinical Trials), school-age children with autism spectrum disorder were enrolled without excluding for medications, thus providing a unique opportunity to examine characteristics of psychotropic medication use in a research cohort and to guide future decisions on medication-related inclusion criteria. The aims of the current analysis were (1) to quantify the frequency and type of psychotropic medications reported in school-age children enrolled in the ABC-CT and (2) to examine behavioral features of children with autism spectrum disorder based on medication classes. Of the 280 children with autism spectrum disorder in the cohort, 42.5% were taking psychotropic medications, with polypharmacy in half of these children. The most commonly reported psychotropic medications included melatonin, stimulants, selective serotonin reuptake inhibitors, alpha agonists, and antipsychotics. Descriptive analysis showed that children taking antipsychotics displayed a trend toward greater overall impairment. Our findings suggest that exclusion of children taking concomitant psychotropic medications in trials could limit the clinical representativeness of the study population, perhaps even excluding children who may most benefit from new treatment options. En ligne : https://doi.org/10.1177/13623613221121425 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=499
in Autism > 27-4 (May 2023) . - p.952-966[article] Concomitant medication use in children with autism spectrum disorder: Data from the Autism Biomarkers Consortium for Clinical Trials [Texte imprimé et/ou numérique] / Logan SHURTZ, Auteur ; Chloe SCHWARTZ, Auteur ; Charlotte DISTEFANO, Auteur ; James C MCPARTLAND, Auteur ; April R LEVIN, Auteur ; Geraldine DAWSON, Auteur ; Natalia M KLEINHANS, Auteur ; Susan FAJA, Auteur ; Sara J WEBB, Auteur ; Frederick SHIC, Auteur ; Adam J NAPLES, Auteur ; Helen SEOW, Auteur ; Raphael A BERNIER, Auteur ; Katarzyna CHAWARSKA, Auteur ; Catherine A SUGAR, Auteur ; James DZIURA, Auteur ; Damla SENTURK, Auteur ; Megha SANTHOSH, Auteur ; Shafali S JESTE, Auteur . - p.952-966.
Langues : Anglais (eng)
in Autism > 27-4 (May 2023) . - p.952-966
Mots-clés : aberrant behavior checklist,antipsychotics,autism spectrum disorders,clinical trials,medications,Vineland Adaptive Behavior Scales Index. décimale : PER Périodiques Résumé : Children with autism spectrum disorder are prescribed various medications to address behavior and mood. In clinical trials, individuals taking concomitant psychotropic medications often are excluded to maintain homogeneity and prevent contamination of clinical endpoints. However, this choice may compromise the representativeness of the sample. In a recent study designed to identify biomarkers and endpoints for clinical trials (the Autism Biomarkers Consortium for Clinical Trials), school-age children with autism spectrum disorder were enrolled without excluding for medications, providing the opportunity to examine characteristics of psychotropic medication use and guide future decisions on medication-related inclusion criteria. The aims of the current analysis were (1) to quantify the frequency and type of psychotropic medications reported in school-age children enrolled in the study and (2) to examine behavioral features of children with autism spectrum disorder based on medication classes. Of the 280 children with autism spectrum disorder in the cohort, 42.5% were taking psychotropic medications, with polypharmacy in half. The most commonly reported psychotropic medications included melatonin, stimulants, selective serotonin reuptake inhibitors, alpha agonists, and antipsychotics. Our findings suggest that exclusion of children taking concomitant psychotropic medications could limit the representativeness of the study population, perhaps even excluding children who may most benefit from new treatment options.Lay abstractChildren with autism spectrum disorder are prescribed a variety of medications that affect the central nervous system (psychotropic medications) to address behavior and mood. In clinical trials, individuals taking concomitant psychotropic medications often are excluded to maintain homogeneity of the sample and prevent contamination of biomarkers or clinical endpoints. However, this choice may significantly diminish the clinical representativeness of the sample. In a recent multisite study designed to identify biomarkers and behavioral endpoints for clinical trials (the Autism Biomarkers Consortium for Clinical Trials), school-age children with autism spectrum disorder were enrolled without excluding for medications, thus providing a unique opportunity to examine characteristics of psychotropic medication use in a research cohort and to guide future decisions on medication-related inclusion criteria. The aims of the current analysis were (1) to quantify the frequency and type of psychotropic medications reported in school-age children enrolled in the ABC-CT and (2) to examine behavioral features of children with autism spectrum disorder based on medication classes. Of the 280 children with autism spectrum disorder in the cohort, 42.5% were taking psychotropic medications, with polypharmacy in half of these children. The most commonly reported psychotropic medications included melatonin, stimulants, selective serotonin reuptake inhibitors, alpha agonists, and antipsychotics. Descriptive analysis showed that children taking antipsychotics displayed a trend toward greater overall impairment. Our findings suggest that exclusion of children taking concomitant psychotropic medications in trials could limit the clinical representativeness of the study population, perhaps even excluding children who may most benefit from new treatment options. En ligne : https://doi.org/10.1177/13623613221121425 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=499
in Implementing the Group-Based Early Start Denver Model for Preschoolers with Autism / Giacomo VIVANTI
Titre : Creating Treatment Objectives in the G-ESDM Type de document : Texte imprimé et/ou numérique Auteurs : Ed DUNCAN, Auteur ; Giacomo VIVANTI, Auteur ; Geraldine DAWSON, Auteur ; Sally J ROGERS, Auteur Année de publication : 2017 Importance : p.31-42 Langues : Anglais (eng) Index. décimale : APP-B APP-B - Modèle de Denver En ligne : http://dx.doi.org/10.1007/978-3-319-49691-7_3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=301 Creating Treatment Objectives in the G-ESDM [Texte imprimé et/ou numérique] / Ed DUNCAN, Auteur ; Giacomo VIVANTI, Auteur ; Geraldine DAWSON, Auteur ; Sally J ROGERS, Auteur . - 2017 . - p.31-42.
in Implementing the Group-Based Early Start Denver Model for Preschoolers with Autism / Giacomo VIVANTI
Langues : Anglais (eng)
Index. décimale : APP-B APP-B - Modèle de Denver En ligne : http://dx.doi.org/10.1007/978-3-319-49691-7_3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=301 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire Designing Research Studies on Psychosocial Interventions in Autism / Tristram SMITH in Journal of Autism and Developmental Disorders, 37-2 (February 2007)
[article]
Titre : Designing Research Studies on Psychosocial Interventions in Autism Type de document : Texte imprimé et/ou numérique Auteurs : Tristram SMITH, Auteur ; Catherine LORD, Auteur ; Geraldine DAWSON, Auteur ; Lawrence SCAHILL, Auteur ; Donald GUTHRIE, Auteur ; Samuel L ODOM, Auteur ; Ann WAGNER, Auteur ; Sally J ROGERS, Auteur Année de publication : 2007 Article en page(s) : p.354-366 Langues : Anglais (eng) Mots-clés : Autism Psychosocial-intervention Behavioral-treatment Clinical-trial Single-subject-design Index. décimale : PER Périodiques Résumé : To address methodological challenges in research on psychosocial interventions for autism spectrum disorder (ASD), a model was developed for systematically validating and disseminating interventions in a sequence of steps. First, initial efficacy studies are conducted to establish interventions as promising. Next, promising interventions are assembled into a manual, which undergoes pilot-testing. Then, randomized clinical trials test efficacy under controlled conditions. Finally, effectiveness studies evaluate outcomes in community settings. Guidelines for research designs at each step are presented. Based on the model, current priorities in ASD research include (a) preparation for efficacy and effectiveness trials by developing manuals for interventions that have shown promise and (b) initial efficacy studies on interventions for core features of ASD such as social reciprocity. En ligne : http://dx.doi.org/10.1007/s10803-006-0173-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=640
in Journal of Autism and Developmental Disorders > 37-2 (February 2007) . - p.354-366[article] Designing Research Studies on Psychosocial Interventions in Autism [Texte imprimé et/ou numérique] / Tristram SMITH, Auteur ; Catherine LORD, Auteur ; Geraldine DAWSON, Auteur ; Lawrence SCAHILL, Auteur ; Donald GUTHRIE, Auteur ; Samuel L ODOM, Auteur ; Ann WAGNER, Auteur ; Sally J ROGERS, Auteur . - 2007 . - p.354-366.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 37-2 (February 2007) . - p.354-366
Mots-clés : Autism Psychosocial-intervention Behavioral-treatment Clinical-trial Single-subject-design Index. décimale : PER Périodiques Résumé : To address methodological challenges in research on psychosocial interventions for autism spectrum disorder (ASD), a model was developed for systematically validating and disseminating interventions in a sequence of steps. First, initial efficacy studies are conducted to establish interventions as promising. Next, promising interventions are assembled into a manual, which undergoes pilot-testing. Then, randomized clinical trials test efficacy under controlled conditions. Finally, effectiveness studies evaluate outcomes in community settings. Guidelines for research designs at each step are presented. Based on the model, current priorities in ASD research include (a) preparation for efficacy and effectiveness trials by developing manuals for interventions that have shown promise and (b) initial efficacy studies on interventions for core features of ASD such as social reciprocity. En ligne : http://dx.doi.org/10.1007/s10803-006-0173-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=640 PermalinkA developmental model for facilitating the social behavior of autistic children / Geraldine DAWSON
PermalinkDigital Behavioral Phenotyping Detects Atypical Pattern of Facial Expression in Toddlers with Autism / Kimberly L. H. CARPENTER in Autism Research, 14-3 (March 2021)
PermalinkDiscrepancies Between Academic Achievement and Intellectual Ability in Higher-Functioning School-Aged Children with Autism Spectrum Disorder / Annette ESTES in Journal of Autism and Developmental Disorders, 41-8 (August 2011)
PermalinkPermalinkDuane F. Alexander, M.D.: August 11, 1940-February 16, 2020 / Fred R. VOLKMAR in Journal of Autism and Developmental Disorders, 50-7 (July 2020)
PermalinkEarly behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder / Geraldine DAWSON in Development and Psychopathology, 20-3 (Summer 2008)
PermalinkPermalinkEarly Social, Imitation, Play, and Language Abilities of Young Non-Autistic Siblings of Children with Autism / Karen TOTH in Journal of Autism and Developmental Disorders, 37-1 (January 2007)
PermalinkEarly Start Denver Model for Young Children with Autism / Sally J ROGERS
Permalink